Company intelligence / Profile preview

Gransker

Munich, Bavaria, Germanyviaplay.no ↗

Ownership: Private
Development stage: Other

Overview

Granzer Regulatory Consulting & Services is a leading European regulatory consultancy supporting pharmaceutical and biotech companies in all phases of drug and device development. They offer strategic guidance from early development through marketing authorization and post-marketing support. Their team includes experts with backgrounds in large pharma, biotech, regulatory authorities, CMC, GMP/GDP compliance, and quality assurance. In addition to regulatory consulting, their spin-off entity offers GMP-related services.

Modalities: Small moleculeOligonucleotideProtein
Industry: Consulting

Beyond the preview

Go deeper on Gransker.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gransker.

Explore the full profile